Media, page-58

The 761 experiment will add a different dimension to immuteps research as will infectious diseases if they
ever get around to it.....Just getting away from the "C" word invokes a different sentiment, not trying to make light
of cancer research, indeed far from it......but immutep are moving toward a different class of patient, one who
has a variety of disorders more uncomfortable than terminal.......
Again not making light of asthma, psoriaris, etc but 761 will be a different clientele with different needs but
still able to get by a bit easier than your average cancer sufferer.....
Hope I didn't offend anyone here because not my intent.....
The source of A/I disease hasn't been tackled before in trials to my knowledge, adds to the mystery, a mystery that
solving could be extremely lucrative.....